publication date: Nov. 22, 2019

Hahn pledges to be guided by “science and data” in considering vape flavor ban if confirmed at FDA

By Alex Carolan

Questions on flavored vaping products dominated the Nov. 20 Senate confirmation hearing for Stephen M. Hahn, the administration’s pick for the job of FDA commissioner.

“I will use science and data to guide the decision if I’m fortunate to be confirmed, and I won’t back away from that,” Hahn, chief medical executive at MD Anderson and professor in the Department of Radiation Oncology, said at the Nov. 20 Senate Committee on Health Education Labor and Pensions hearing.

The question of the ban has become something of a slippery slope in today’s Washington. In September, Trump said the administration was working with FDA to ban vaping flavors, which studies show appeal to youths and can lead to nicotine addiction. The plan was to enact a ban within a month.

However, earlier this week, the president said he no longer supports regulation of e-cigarette flavors. Protesters, criticism, the potential to negatively affect the economy and lose voters in battleground states resulted in the abrupt change of course, The Washington Post reported earlier this week.

In his Senate confirmation hearing, Hahn acknowledged that the rise in e-cigarette use among youths “is an important, urgent crisis in this country,” but made no specific pledges as Democratic and Republican Senate members pressed him on whether he would resist pressure from the administration and lobbying groups.

“I understand that the compliance policy is under consideration by the administration, and I look forward to their decision,” Hahn said. “I am not privy to those decision-making processes, but I very much agree and support that aggressive … Continue reading Hahn pledges to be guided by “science and data” in considering vape flavor ban if confirmed at FDA

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.